Table A1.
Author, year, study design | Setting and sample size | Admission criteria | Intervention treatment | Control treatment | Length of int | Outcomes reported | Food better than control? | Validity scoreα |
---|---|---|---|---|---|---|---|---|
Nikièma et al., 2014 Cluster RCT |
Burkina Faso
N = 1,974 |
Aged 6–24 months WHO, 2006 (WHZ > −2 and ≥−3) |
|
Child‐centred counselling (CCC) | 3 m |
Recovery: RUSF 74%, SC+ 75%, CCC 58% p < .0001 Default: RUSF 7%, SC+ 4%, CCC 19% p < .003 SAM: RUSF 8%, SC+ 10%, CCC 12% p < .05 When restricted to nondefaulters, recovery = 71%, 78%, and 80% for CCC, SC+, and RUSF. |
Yes | ++/+ |
Micronutrients provided to control groups | ||||||||
Hossain, Ahmed, & Brown, 2012, 2014, 2016 (conference abstracts) Cluster RCT |
Bangladesh
N = 227 |
Aged 6–24 months WHZ < −2 to −3 (WHO, 2006) |
|
|
3 m | Follow‐up attendance and gain in weight and length were greater in groups SF, SF + PS, and PS than CC and HC. | Maybe: Not possible to distinguish between benefits of supplement versus psychosocial stimulation | −/− |
Javan et al., 2017 RCT |
Iran
N = 70 |
Aged 9–24 months with WLZ < −2 and ≥−3 and referred for treatment | Blended flour supplementary food (chickpea, rice, wheat, barley, and sugar) + multivitamins + nutritional counselling (SF) | Multivitamins + nutritional counselling (C) | 3 m |
Recovery rate: SF 68%, C 32% p = .001 Weight gain (g): SF 0.81, C 0.55, p = .002 WLZ gain: 0.36, C 0.02 p = .003 |
Yes | ++/++ |
Not recruited based on current MAM definitions | ||||||||
van der Kam et al., 2016 RCT |
Nigeria
N = 2,213
25% of sample had MAM at enrolment |
Aged 6 to 59 months and diagnosed with malaria, diarrhoea, or LRTI
MAM= WHZ <−2 and >−3, and MUAC >115 mm |
|
|
14 days |
Incidence rate of SAM in MAM children: RUTF 0.70, MNP 0.71, C 0.71
p > .05 for RUTF versus MNP and RUTF versus C |
No: Incidence of SAM was same for RUTF group to MNP group and no supplement group. | ++/+ |
Roy et al., 2005 Cluster randomised trial |
Bangladesh
N = 282 |
Aged 6–24 months, WA 61– 75% of median NCHS |
|
|
3 m |
Recovery rate (WAM): INE + SF 47%, INE 37%, C 18% p < .001 Recovery 6 months after end of intervention (WAM): INE + SF 86%, INE 59%, C 30% p < .0001 |
Yes | ++/+ |
Fauveau et al., 1992 RCT |
Bangladesh
N = 134 |
Aged 6 to 12 months, MUAC > 110 and <129 mm, living in bamboo structure |
Supplementary food (rice, wheat, lentils, and oil; SF) | Nutrition education (C) | 6 m |
Monthly weight gain in first 3 months: SF 205 g, C 159 g p < .05 Monthly weight gain in 6 months: SF 179 g, C 128 g p > .05
No significant difference in diarrhoea or other morbidities. |
Maybe: Food group have larger weight gain in first 3 months but not whole 6 months | ++/+ |
Not recruited based on current mam definitions and micronutrients provided to control groups | ||||||||
Hossain, Nahar, Hamadani, Ahmed, & Brown, 2011 RCT |
Bangladesh
N = 507
81% of sample had WLZ < −2 at baseline |
Aged 6‐24 months and WAZ <−3 and recovered from diarrhoea at the hospital (NCHS)
Results stratified by WLZ <−2 |
|
|
3 m |
Whole sample: Weight gain (kg): HC 0.60, CC 0.79, C–PS 0.83, C–SF 0.92, C–SF+PS 0.90 (SF versus no SF p=0.009) Severe illness rate: No significant difference Attendance at 5th visit: 54% with SF, 40% without SF
For those with WLZ < −2 WLZ gain: HC 0.65, CC 0.65, C–PS 0.87, C–SF 0.94, C−SF + PS 1.19 LAZ gain: HC −0.41, CC −0.29, C−PS −0.33, C−SF −0.20, C−SF + PS −0.15 |
Yes | ++/+ |
Heikens, Schofield, Dawson, & Grantham‐McGregor, 1989 RCT |
Jamaica
N = 82 |
Aged 3–36 months and <80% WAZ using NCHS | High energy supplement for 3 months plus weekly home visits and micronutrient supplements for 6 months (HES) | Home visits and micronutrient supplements for 6 months (HV) | 3m |
WAZ after 3 months: HES −2.6, HV −3.1, p = .007 WHZ and WAZ after 6 months: not significantly different between HES and HV groups HAZ after 6 months: HES −2.1, HV −2.7, p = .03 |
Yes, marginally | +/+ |
Preventative trials: majority adequately nourished children | ||||||||
Schlossman et al., 2017 Pilot cluster RCT |
Guinea Bissau
N = 681 |
Children aged 6–59 months with WHZ < 2 or WAZ < 1 or HAZ < 2 and their mothers |
|
No intervention (C) | 3 m |
Infants 6–23 months: Change in WHZ: RUSF33 0.28, RUSF15 0.12, C 0.26 p > .05 Change in MUAC: RUSF33 0.62, RUSF15 0.46, C 0.28 p > .05 Haemoglobin: RUSF33 0.71, RUSF15 0.87, C 0.06 p > .05 Retinol‐binding protein: RUSF33‐0.05, RUSF15‐0.09, C 0.05 p > .05 |
No: Controls improved an equal extent to food group. | +/− |
Christian et al., 2015 Cluster RCT |
Bangladesh
N = 5,421 |
All infants aged 6 months in the catchment area |
|
|
12 m |
At 18 months Prevalence stunting: RUSF–R 44%, RUSF–C 39%*, PD 40%*, WSB 44%, C 44% Prevalence wasting (WLZ): RUSF–R 16%, RUSF–C 16%, RUSF–S 14%*, WSB 18%, C 16% Prevalence underweight: RUSF–R 39%, RUSF–C 35%*, RUSF−S 33%*, WSB 40%, C 39% (*p < .05 when compared with control) |
Yes for RUSF−S, No benefit of WSB++ over counselling |
++/++ |
Grellety et al., 2012 Prospective cohort |
Niger
N = 2,238
18% of sample WLZ < −2 |
All children 60–80 cm length (approx. age 6−23 months)
18% of sample WLZ < −2 |
|
|
4 m |
MUAC gain (mm): LNS–MQ −2.8, C −4.0 p = .002 WLZ gain: LNS–MQ −0.2, C −0.3 p = .006 Rate of wasting per 100 child‐months: LNS–MQ 3.9, C 4.2 p = .05 Rate of stunting per 100 child‐months: LNS–MQ 26.8, C 14.4 p = .87 Mortality rate per 100 child‐months: LNS–MQ 1.6, C 2.4 p = .03 |
Yes | +/− |
Note.. Risk of bias score is presented as internal/external score; (−) Poor quality, (+) Adequate quality, (++) good quality. See “WFP Specialized Nutritious Food Sheet” for detailed definitions of common supplements; see individual papers for full details of nutrient content of each supplement.
Abbreviations: LNS–MQ, lipid‐based nutrient supplement medium quantity; LRTI, lower respiratory tract infection; RUSF, ready‐to‐use supplementary food; Supercereal Plus, micronutrient fortified corn–soy‐blended flour, formally called CSB++; RCT, randomized controlled trial; WAM, weight for age median.